Vexler Vladimir 4
4 · Coherus BioSciences, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4
Vexler Vladimir
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-09−20,312→ 4,688 totalExercise: $9.30Exp: 2027-11-15→ Common Stock (20,312 underlying) - Exercise/Conversion
Common Stock
2021-03-09$2.08/sh+24,356$50,753→ 89,502 total - Exercise/Conversion
Common Stock
2021-03-09$9.30/sh+20,312$188,902→ 109,814 total - Exercise/Conversion
Common Stock
2021-03-09$10.05/sh+57,812$581,011→ 167,626 total - Sale
Common Stock
2021-03-09$16.25/sh−114,240$1,856,263→ 53,386 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-09−24,356→ 0 totalExercise: $2.08Exp: 2023-02-28→ Common Stock (24,356 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-09−57,812→ 17,188 totalExercise: $10.05Exp: 2028-02-01→ Common Stock (57,812 underlying)
Footnotes (5)
- [F1]Includes 52,083 restricted stock units.
- [F2]The transaction was executed in multiple trades at prices ranging from $16.071 to $16.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]All of the shares underlying this option are vested and exercisable as of the date hereof.
- [F4]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 15, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F5]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.